Atai Beckley Inc. ( ATAI) - Stock Earnings
Stock symbol ATAI is outdated, potentially delisted? Maybe it is available on other exchange?
ATAI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
ATAI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -544.8 million USD | 1.1 million USD |
| 2026Q1 | -29.8 million USD | 953999 USD |
| 2026Q2 | -32.5 million USD | 1.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ATAI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -40.2 million USD | 314000 USD |
| 2024 | -149.3 million USD | 308000 USD |
| 2025 | -660.0 million USD | 4.1 million USD |
| 2026 Est. | — | — |
ATAI
Price: $7.35
52 week price:
Earnings Per Share: -2.79 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 1.5 million
Ebitda: 9.8 millionMarket Capitalization: 2.7 billion